Belite Bio (BLTE) Assets Average (2023 - 2026)

Belite Bio's Assets Average history runs 4 years deep, the most recent figure standing at $795.9 million for Q1 2026.

• In Q1 2026, Assets Average rose 403.21% year-over-year to $795.9 million; the TTM figure through Mar 2026 stood at $795.9 million (up 403.21% YoY), while the FY2025 annual figure was $466.3 million, up 277.95% from the prior year.
• Assets Average was $795.9 million for Q1 2026 at Belite Bio, up from $531.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $795.9 million in Q1 2026 to a low of $42.0 million in Q1 2023.
• Historically, Assets Average has averaged $196.3 million across 4 years, with a median of $117.1 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Assets Average soared 46.01% in 2025, then jumped 403.21% in 2026.
• A 4-year view of Assets Average shows it stood at $76.1 million in 2023, then jumped by 76.01% to $134.0 million in 2024, then soared by 296.69% to $531.5 million in 2025, then jumped by 49.76% to $795.9 million in 2026.
• The last three Assets Average figures came in at $795.9 million (Q1 2026), $531.5 million (Q4 2025), and $219.4 million (Q3 2025), per Business Quant data.